$1 Billion J&J Settlement Rejected as Insufficient


Federal prosecutors have rejected as insufficient the $1 billion settlement reached two months ago between Johnson & Johnson and prosecutors in Philadelphia to resolve claims related to fraudulent and unapproved marketing of Risperdal for, among other things, children and the elderly.

Article →                                                   Discuss →


Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

Previous articleNotes on a Scandal
Next articleScientific American Reviews “Anatomy of an Epidemic”
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected]


  1. I’m not sure what dollar amount would be compensation for the injury caused by J&J.

    What’s a life worth?
    A thousand lives?
    Tens of thousands?

    Because, make no mistake, lives were lost.
    By premature death.
    And by severely dimishing the quality of life.

    A summation on justice –


    “If you want peace, search for justice.” – Pope Paul VI

    Duane Sherry